Scholars Central

Research articlePublished 2012

Metformin Reduces Left Ventricular Eccentric Re-modeling In Experimental volume Overload in the Rat

Authors: Wahiba Dhahri, Élise Roussel, Marie-Claude Drolet, Suzanne Gascon, Otman Sarrhini, Jacques A. Rousseau, Roger Lecomte, Jacques Couet, Marie Arsenault

Clinical and Experimental Cardiology

Volume 3 · Issue 11 · Pages 1–8

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Left ventricular hypertrophy (LVH) is often associated with a change in myocardial energy substrate preference from fatty acids to glucose. A possible anti hypertrophic treatment strategy could aim at stimulating or restoring normal myocardial energy metabolism. Metformin, an adenosine monophosphate-activated protein kinase (AMPK) activator used in the management of glucose metabolism in diabetes, is also a fatty acid oxidation stimulator. The effect of metformin on the development of eccentric LVH and ventricular function in chronic left ventricular (LV) volume overload (VO) is unknown. This study was designed to study this question in a VO rat model caused by severe aortic valve regurgitation (AR). Male Wistar rats were divided in four groups (13-15 animals / group): Shams (S) treated or not (C) with metformin (M; 100 mg/kg/d PO) and severe ARreceiving or not metformin. Treatment was started one week before surgery and the animals were sacrificed 9 weeks later. As expected AR rats developed severe eccentric LVH during the course of the protocol. Metformin treatment did not influence the total heart weight. However, LV remodeling associated with the severe VO was severe in ARM than in ARC. Fractional shortening, a marker of systolic function, was significantly higher in ARM compared to ARC group. Metformin also increased the activity of enzymes associated with fatty acid oxidation while inhibiting phosphofructokinase, a glycolytic enzyme. A 2 month treatment with metformin reduced LV eccentric remodeling associated with severe VO and helped maintain a better systolic function.

Subjects

Cardiology

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Clinical and Experimental Cardiology.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalClinical and Experimental Cardiology
  • SubjectCardiology
  • BylineArticles whose byline prints “Wahiba Dhahri”
  • BylineArticles whose byline prints “Élise Roussel”
  • BylineArticles whose byline prints “Marie-Claude Drolet”
  • BylineArticles whose byline prints “Suzanne Gascon”
  • BylineArticles whose byline prints “Otman Sarrhini”
  • BylineArticles whose byline prints “Jacques A. Rousseau”
  • BylineArticles whose byline prints “Roger Lecomte”
  • BylineArticles whose byline prints “Jacques Couet”